4//SEC Filing
Marsh Martha H. 4
Accession 0001225208-22-006244
CIK 0001099800other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 9:02 PM ET
Size
8.6 KB
Accession
0001225208-22-006244
Insider Transaction Report
Form 4
Marsh Martha H.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-04-28$25.99/sh+28,722$746,436→ 55,499 total - Sale
Common Stock
2022-04-28$108.09/sh−28,722$3,104,564→ 26,777 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2022-04-28−28,722→ 0 totalExercise: $25.99From: 2016-11-19Exp: 2022-11-18→ Common Stock (28,722 underlying)
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $108.00 to $108.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001500281
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 9:02 PM ET
- Size
- 8.6 KB